Dr Agarwals Eye Hospital Limited Stock Price Today (NSE: DRAGARWQ)
Fundamental Score
Dr Agarwals Eye Hospital Limited Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Dr Agarwals Eye Hospital Limited share price today is ₹5077.00, down 1.67% on NSE/BSE as of 16 October 2026. Dr Agarwals Eye Hospital Limited (DRAGARWQ) is a Small-cap company in the Hospital sector with a market capitalisation of ₹2.45K (Cr). The 52-week high for DRAGARWQ share price is ₹5500.00 and the 52-week low is ₹5035.50. At a P/E ratio of 35.01x, DRAGARWQ is currently trading below its industry average P/E of 48.79x. The company has a Return on Equity (ROE) of 25.22% and a debt-to-equity ratio of 0.94.
Dr Agarwals Eye Hospital Limited Share Price Chart — NSE/BSE Historical Performance
Dr Agarwals Eye Hospital Limited share price chart: -3.65% return over the past month. 52-week high ₹5500.00, 52-week low ₹5035.50.
Dr Agarwals Eye Hospital Limited — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹5162.50 | ₹5162.50 | ₹5035.50 | ₹5077.00 | 10.86K (Cr) | |
| ₹5148.00 | ₹5200.00 | ₹5110.00 | ₹5163.00 | 579.00 (Cr) | |
| ₹5220.00 | ₹5220.00 | ₹5125.00 | ₹5148.00 | 376.00 (Cr) | |
| ₹5256.50 | ₹5256.50 | ₹5110.00 | ₹5136.00 | 2.85K (Cr) | |
| ₹5121.00 | ₹5246.50 | ₹5054.50 | ₹5199.00 | 1.49K (Cr) | |
| ₹5180.00 | ₹5180.00 | ₹5106.50 | ₹5161.50 | 421.00 (Cr) | |
| ₹5200.00 | ₹5269.00 | ₹5132.00 | ₹5160.50 | 590.00 (Cr) | |
| ₹5200.00 | ₹5242.50 | ₹5154.00 | ₹5198.00 | 1.89K (Cr) | |
| ₹5215.00 | ₹5323.50 | ₹5161.00 | ₹5195.00 | 1.62K (Cr) | |
| ₹5250.00 | ₹5294.00 | ₹5162.50 | ₹5215.00 | 2.78K (Cr) |
Dr Agarwals Eye Hospital Limited — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹5165.50 | ₹5323.50 | ₹5035.50 | ₹5077.00 | -1.71% | |
| ₹5295.00 | ₹5500.00 | ₹5061.00 | ₹5130.00 | -3.12% | |
| ₹5020.20 | ₹5500.00 | ₹4936.35 | ₹5266.00 | +4.90% | |
| ₹4701.05 | ₹5175.55 | ₹4701.05 | ₹4995.00 | +6.25% | |
| ₹5025.00 | ₹5205.90 | ₹4702.00 | ₹5099.95 | +1.49% | |
| ₹4983.95 | ₹5740.00 | ₹4795.00 | ₹4973.55 | -0.21% | |
| ₹4879.95 | ₹5200.00 | ₹4612.50 | ₹4983.95 | +2.13% | |
| ₹4460.00 | ₹4990.00 | ₹4425.00 | ₹4699.55 | +5.37% | |
| ₹4626.00 | ₹4950.00 | ₹4498.40 | ₹4599.95 | -0.56% | |
| ₹5340.05 | ₹6392.00 | ₹4412.05 | ₹4650.20 | -12.92% | |
| ₹5772.00 | ₹5840.00 | ₹5099.00 | ₹5334.35 | -7.58% | |
| ₹5384.10 | ₹5890.00 | ₹5013.15 | ₹5735.30 | +6.52% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Dr Agarwals Eye Hospital Limited Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Dr Agarwals Eye Hospital Limited Fundamental Analysis & Valuation Benchmarking
Educational evaluation of DRAGARWQ across key market metrics for learning purposes.
Positive Indicators
11 factors identified
Strong Return on Equity (25.22%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (17.36%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Strong Operating Margins (29.73%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Attractive Valuation (P/E: 35.01 vs Industry: 48.79)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Strong Revenue Growth (20.21%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Consistent Growth Track Record (27.49% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Excellent EPS Growth (118.39% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential.
Strong Profit Growth Track Record (119.56% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Strong Interest Coverage (8.88x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Strong Cash Generation (₹68.40 Cr over 5Y)
Observation: Healthy free cash flow generation supports growth and returns.
Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.
Balanced Promoter Holding (72.67%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Risk Factors
3 factors identified
High Price-to-Book Ratio (11.38x)
Observation: Trading at significant premium to book value.
Analysis: High P/B ratios may indicate overvaluation relative to asset base.
Liquidity Concerns (Current Ratio: 0.64)
Observation: Current assets may not adequately cover short-term liabilities.
Analysis: Current ratio <1.0 raises working capital concerns.
Limited Institutional Interest (FII+DII: 4.32%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
Dr Agarwals Eye Hospital Limited vs Hospital Peers
Peer Comparison - Hospital
Compare Dr Agarwals Eye Hospital Limited with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Dr Agarwals Eye Hospital LimitedDr Agarwals Eye...Selected✓ DRAGARWQ • 526783 | 72.5/100 | ₹5077.00₹5077 | ₹2454.24₹2454.24 | 35.01Average 35.0 Average | 25.22%Excellent 25.22% Excellent | 17.36%Good 17.36% Good | 0.94Good 0.9 Good | 119.56%Excellent 119.56% Excellent | 27.49%Excellent 27.49% Excellent | 0.12% |
Apollo Hospitals Enterprise LimitedApollo Hospital... APOLLOHOSP • 508869 | 64.1/100 | ₹7890.00₹7890 | ₹113458.20₹113458.20 | 54.29Average 54.3 Average | 21.95%Excellent 21.95% Excellent | 19.28%Good 19.28% Good | 0.60Good 0.6 Good | 66.81%Excellent 66.81% Excellent | 19.03%Excellent 19.03% Excellent | 0.22% |
Max Healthcare Institute LimitedMax Healthcare ... MAXHEALTH • 543220 | 55.5/100 | ₹846.00₹846 | ₹82336.10₹82336.10 | 56.44Average 56.4 Average | 14.33%Average 14.33% Average | 13.43%Average 13.43% Average | 0.32Excellent 0.3 Excellent | 60.01%Excellent 60.01% Excellent | 27.30%Excellent 27.30% Excellent | 0.18% |
Fortis Healthcare LimitedFortis Healthca... FORTIS • 532843 | 50.6/100 | ₹736.50₹737 | ₹55602.80₹55602.80 | 53.06Average 53.1 Average | 11.08%Average 11.08% Average | 12.83%Average 12.83% Average | 0.29Excellent 0.3 Excellent | 64.38%Excellent 64.38% Excellent | 17.76%Excellent 17.76% Excellent | 0.10% |
Narayana Hrudayalaya Ltd.Narayana Hruday... NH • 539551 | 65.7/100 | ₹1719.40₹1719 | ₹35137.83₹35137.83 | 42.79Average 42.8 Average | 19.74%Good 19.74% Good | 14.53%Average 14.53% Average | 1.07Average 1.1 Average | 155.30%Excellent 155.30% Excellent | 25.05%Excellent 25.05% Excellent | 0.22% |
Aster DM Quality Care LimitedAster DM Qualit... ASTERDM • 540975 | 49.5/100 | ₹674.35₹674 | ₹34940.10₹34940.10 | 109.12Average 109.1 Average | 9.70%Poor 9.70% Poor | 11.35%Average 11.35% Average | 0.15Excellent 0.2 Excellent | 21.31%Excellent 21.31% Excellent | -11.61%Poor -11.61% Poor | 0.61% |
Global Health LimitedGlobal Health L... MEDANTA • 543654 | 57.9/100 | ₹1240.00₹1240 | ₹33327.48₹33327.48 | 59.90Average 59.9 Average | 15.15%Good 15.15% Good | 16.85%Good 16.85% Good | 0.30Excellent 0.3 Excellent | 80.71%Excellent 80.71% Excellent | 24.97%Excellent 24.97% Excellent | 0.04% |
27.7/100 | ₹685.60₹686 | ₹28795.20₹28795.20 | 134.43Average 134.4 Average | 11.01%Average 11.01% Average | 9.35%Poor 9.35% Poor | 1.44Average 1.4 Average | 3.71%Average 3.71% Average | 24.04%Excellent 24.04% Excellent | 0.00% | |
Dr. Agarwal's Health Care LimitedDr. Agarwal's H... AGARWALEYE • 544350 | 57.3/100 | ₹465.80₹466 | ₹14765.86₹14765.86 | 99.32Average 99.3 Average | 6.84%Poor 6.84% Poor | 10.16%Average 10.16% Average | 0.08Excellent 0.1 Excellent | 34.42%Excellent 34.42% Excellent | 34.58%Excellent 34.58% Excellent | 0.00% |
Rainbow Childrens Medicare LimitedRainbow Childre... RAINBOW • 543524 | 73/100 | ₹1248.90₹1249 | ₹12684.58₹12684.58 | 44.43Average 44.4 Average | 17.86%Good 17.86% Good | 18.10%Good 18.10% Good | 0.00Excellent 0.0 Excellent | 44.04%Excellent 44.04% Excellent | 21.24%Excellent 21.24% Excellent | 0.23% |
Yatharth Hospital & Trauma Care Services LimitedYatharth Hospit... YATHARTH • 543950 | 66.1/100 | ₹992.10₹992 | ₹9559.28₹9559.28 | 52.77Average 52.8 Average | 9.98%Poor 9.98% Poor | 12.29%Average 12.29% Average | 0.14Excellent 0.1 Excellent | 57.39%Excellent 57.39% Excellent | 41.18%Excellent 41.18% Excellent | 0.00% |
Top Hospital Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Apollo Hospitals Enterprise Limited share price113458.20 Cr
- Max Healthcare Institute Limited share price82336.10 Cr
- Fortis Healthcare Limited share price55602.80 Cr
- Narayana Hrudayalaya Ltd. share price35137.83 Cr
- Aster DM Quality Care Limited share price34940.10 Cr
Dr Agarwals Eye Hospital Limited PE Ratio History
Historical price-to-earnings ratio for DRAGARWQ — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2025 | ₹116.28 | ₹5334.35 | 45.9x |
| FY 2024 | ₹98.64 | ₹6147.10 | 62.3x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Dr Agarwals Eye Hospital Limited Dividend History
Annual cash dividends paid by DRAGARWQ — dividend yield 0.12%
| Financial Year | Dividends Paid (₹ Cr) |
|---|---|
| FY 2025 | ₹2.35 Cr |
| FY 2024 | ₹2.58 Cr |
| FY 2023 | ₹1.41 Cr |
| FY 2022 | ₹0.02 Cr |
Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.
Dr Agarwals Eye Hospital Limited Quarterly Performance
Latest quarterly metrics for DRAGARWQ — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
20.21%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
1.56%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
27.49%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
119.56%
Compounded annual net profit growth over 5 years
Dr Agarwals Eye Hospital Limited Technical Indicators
SMA 50, SMA 200, RSI and volume signals for DRAGARWQ — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Dr Agarwals Eye Hospital Limited Financial Statements
Annual income statement, balance sheet and cash flow for Dr Agarwals Eye Hospital Limited (DRAGARWQ) — sourced from NSE/BSE filings.
Financial Results & Statements
Latest quarterly, annual and period-wise financial data for Dr Agarwals Eye Hospital Limited
About DRAGARWQ (Dr Agarwals Eye Hospital Limited)
Dr. Agarwals Eye Hospital Ltd is a prominent healthcare institution dedicated to preserving and restoring vision across a wide geographical expanse. Beyond the familiar walls of tr...aditional hospitals, it functions as a network of specialized eye care centers, each a beacon of hope for individuals struggling with visual impairments. The hospital distinguishes itself by combining cutting-edge medical technology with the expertise of a dedicated team of ophthalmologists, surgeons, and support staff. Their commitment extends to every aspect of eye health, from comprehensive diagnostics to intricate surgical procedures, creating a holistic approach that prioritizes patient well-being. This institution stands as a testament to innovation in the realm of ophthalmology, continually pushing the boundaries of what is possible in visual care. The hospital's comprehensive suite of services addresses a spectrum of ocular conditions, catering to both common ailments and complex disorders. They offer advanced treatments for prevalent issues such as cataracts and refractive errors, allowing patients to regain clear sight. In addition, Dr. Agarwals Eye Hospital provides specialized care for more intricate conditions like glaucoma, retinal diseases, and corneal disorders. The hospital uses modern methods to correct the position of the eye and make sure it looks right. Whether it's a routine check-up or a demanding surgical intervention, the focus remains unwavering: to provide personalized treatment plans that cater to the unique needs of each patient. Through their commitment to individualized care, the hospital aims to enhance not only vision but also the overall quality of life. Dr. Agarwals Eye Hospital has made a commitment to worldwide access to quality eye care, therefore, they have geographically diverse practices that demonstrate the organization's broad vision. The business provides a full array of services, bringing excellent eye care to diverse communities in India as well as countries in Africa and the Indian Ocean. Each facility is designed to satisfy the particular requirements of the surrounding region, ensuring that people can obtain top-notch eye care regardless of where they are. By broadening their scope, Dr. Agarwals Eye Hospital solidifies its role as a global leader in ophthalmology, transforming lives and strengthening communities by means of vision.
Company Details
Key Leadership
DRAGARWQ Share Price: Frequently Asked Questions
What is the current share price of Dr Agarwals Eye Hospital Limited?
Dr Agarwals Eye Hospital Limited (DRAGARWQ) trades at ₹5077.00 on NSE and BSE. Market cap ₹2.45K (Cr). Educational data only.
What is the P/E ratio of Dr Agarwals Eye Hospital Limited?
Dr Agarwals Eye Hospital Limited has a P/E of 35.01x vs industry average 48.79x.
What is the Bull Run score for Dr Agarwals Eye Hospital Limited?
Dr Agarwals Eye Hospital Limited has a Bull Run score of 72.5/100 based on 25+ financial parameters.
Does Dr Agarwals Eye Hospital Limited pay dividends?
Dr Agarwals Eye Hospital Limited has a dividend yield of 0.12%. Past dividends don't guarantee future payments.
What is the ROE of Dr Agarwals Eye Hospital Limited?
Dr Agarwals Eye Hospital Limited has ROE of 25.22%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Dr Agarwals Eye Hospital Limited?
Dr Agarwals Eye Hospital Limited has debt-to-equity of 0.94.
Is Dr Agarwals Eye Hospital Limited a good investment?
Bull Run gives Dr Agarwals Eye Hospital Limited a score of 72.5/100. This is not investment advice — consult a SEBI-registered advisor.